Teaching Registrars Research Methods Study design - PowerPoint PPT Presentation

1 / 59
About This Presentation
Title:

Teaching Registrars Research Methods Study design

Description:

Title: Study design Author: Landon Myer Last modified by: Landon Myer Created Date: 10/23/2005 10:14:00 AM Document presentation format: On-screen Show – PowerPoint PPT presentation

Number of Views:305
Avg rating:3.0/5.0
Slides: 60
Provided by: Lando3
Category:

less

Transcript and Presenter's Notes

Title: Teaching Registrars Research Methods Study design


1
Teaching Registrars Research Methods Study design
  • Landon Myer PhD
  • Senior Lecturer, Infectious Diseases Epidemiology
    Unit, School of Public Health, UCT
  • lmyer_at_cormack.uct.ac.za

2
Orientation to todays session
  • So far
  • Introduction
  • Study protocol
  • Reviewing the Literature
  • Today ? Study design ?
  • To come
  • Sampling
  • Measurement
  • Data analysis
  • Ethics

All of one interrelated process
3
Overview
  • How to start to select a study design
  • Framework for considering different study designs
  • Key similarities differences
  • Introduction to each major category of study
    design
  • Focus on major functional features
  • Strengths limitations
  • Examples
  • Exercises

Ask questions throughout!
4
Note on terminology
  • Outcomes
  • Health outcome of interest in the study
  • Disease, death, side effect, complication
  • (stats dependent variables)
  • Exposures
  • Measures that may be associated with the outcome
  • Possible risk factors, causes, determinants
  • (stats independent variables)

5
I. Framework for thinking about study designs
6
What are study designs?
  • Structured approaches to address specific
    research questions
  • Provide general guidelines for thinking about
    specific aspects of study conduct
  • sampling populations
  • systematically collecting measurements
  • analysing data
  • Strengths limitations of specific designs are
    well-established

7
How to select a study design
  • Start with a good study question
  • Relevant
  • Addresses topic of significance to health of
    local population / health care services
  • Novel
  • Makes meaningful contribution to existing
    knowledge new insights
  • Feasible
  • Not overly ambitious

Creativity
8
Different types of study questions lead to
different types of study designs
  • Descriptive
  • What is the prevalence of condition Z in a
    specific population?
  • Analytic
  • What are the factors associated condition Z? Is
    condition X a risk factor for condition Z?
  • Diagnostic
  • How good is test Q in detecting condition Z?

9
Selecting the right study design option
  • Relevant
  • Design allows you to answer your research
    question
  • Novel
  • Design allows meaningful contribution to existing
    knowledge new insights
  • Feasible
  • Design allows study to be done within available
    time and funds
  • Simple
  • ALWAYS avoid ALL unnecessary complexities

10
Types of study designs
  • Many types
  • Most are some variation on general themes
    presented here
  • All designs based on same basic principles
  • key differences in how study design samples
    participants with respect to
  • exposures (risk factors, patient
    characteristics)
  • outcomes (diseases, conditions)

11
Choice of study design closely related to other
aspects of protocol
  • Study design choices inform how you will sample a
    specific study population
  • in a way that its understood how the participants
    in the study relate to the population in general
  • 2. Study design choices inform the most
    appropriate measurements to collect on
    participants in a standardised manner (create
    data)

12
  • 3. Study designs will point to the most
    appropriate analysis of data to answer study
    question
  • Descriptive
  • Calculate the proportion of the study population
    with condition Z (incident or prevalent)
  • Analytic
  • Compare the frequency of condition Z among groups
    of the population
  • Diagnostic
  • Calculate the validity (sensitivity/specificity)
    or reliability of test Q in detecting condition Z

13
Broad categories of options in study design
  • Cross-sectional
  • Case report / case series
  • Case-control
  • Cohort
  • Randomised Controlled Trial (RCT)

14
Broad categories of options in study design
  • Cross-sectional
  • Case series
  • Case-control
  • Cohort
  • Randomised Controlled Trial

Diagnostic
?
Descriptive
Analytic
15
Broad categories of options in study design
  • Cross-sectional
  • Case report/series
  • Case-control
  • Cohort
  • RCT

Observational designs investigator is only
observing distribution of variables (risk
factors, diseases, etc) in nature
Experimental designs investigator assigns study
conditions usually testing an intervention
(many variations here)
16
Key differences between study designs
  • How participants are sampled
  • Are participants sampled according to exposure
    status, disease status, neither, both?
  • When measurements are taken
  • Are some variables measured before others, or are
    measurements taken all at once?
  • How outcome variables are measured
  • Incident or prevalent outcomes (morb/mort)?
  • Are there comparison groups involved?
  • Is design observational or experimental?

17
Time marches on
  • Onset of conditions takes place over time in
    populations
  • Different study designs deal with the onset of
    conditions through time in different ways
  • Critical to understand how your choice of study
    design handles the timing of
  • Identification of participants
  • Measurement of variables (exposure, disease)

18
X onset of condition of interest
1
X
Died
2
Died
3
4
5
X
Died
6
7
X
8
X
Died
9
X
10
X
Died
11
Time
19
II. Details on categories of study designs
  • Case report case series
  • Case-control
  • Cross-sectional
  • Cohort
  • RCT other experimental designs

20
Case-report case-series
  • Cases
  • people with health outcome
  • depends on what is of interest
  • Case report / series
  • Describes
  • characteristics of disease / condition
  • characteristics of individual that may be
    associated with the condition

21
Issues in case-only designs
  • Useful for descriptive purposes only
  • Implicit comparisions to what is expected or
    normal
  • Why might this be problematic?

vs
22
Case-control studies
  • Set of cases (usually from health service)
  • Comparable set of controls (various sources)
  • Both groups evaluated on characteristics /
    exposures of interest
  • Compare distribution of exposure in cases and
    controls

23
Exposed
Cases
Unexposed
Exposed
Controls
Unexposed
24
Exposed
Cases
Unexposed
Exposed
Controls
Unexposed
Time
25
Example Does childrens inhalation of hairspray
facilitates development of asthma?
  • 50 new cases of severe asthma identified at RXH
    in 12-month period, all lt5 yrs of age
  • These cases are compared to
  • 90 children lt5 years attending
  • RXH for orthopedic surgery
  • (who do not have asthma)
  • Cases and controls are
  • compared on maternal hairspray
  • use since childs birth

26
Hairspray
Children with asthma
No hairspray
Hairspray
Children without asthma
No hairspray
27
Odds ratio in 2x2 table
  • Odds ratio (A/C) / (B/D)

28
Strengths limitations of case-control study
  • Relatively simple quick approach to address
    analytic questions
  • Ideal to study rare diseases (vs cohort)
  • Cases potential controls are accessible in
    health care setting
  • Choice of the wrong control group selection
    bias
  • Cases may over-report past exposures
    information bias

29
Cross-sectional studies
  • Most common form of research surveys
  • Measure all variables on participants at same
    point in time (approximately)
  • Measure prevalent disease (not incidence)

X Disease
X Exposure
Time
30
Defined population
Sampling
Collect data on outcome (disease) and exposure
(risk factors)
Exposed Diseased
Exposed Not diseased
Not exposed Diseased
Not exposed Not Diseased
31
Example How severe is disease among rheumatoid
arthritis patients attending GSH?
  • Study population patients attending rheumatology
    clinic at GSH during one month period
  • Measures degree of disease severity (outcome)
    demographics, disease history, treatment history
    (exposures)
  • Analysis prevalence of severe disease in clinic
    population association between severity of
    disease and different exposures

32
Benefits of cross-sectional study
  • Feasibility ? easy to do
  • In health care setting, can work from existing
    records (consent issues)
  • Low cost, rapid
  • Not waiting for incident outcomes to develop
  • Can calculate prevalence
  • Often most relevant measure for burden of
    disease, informing health care strategies
  • Measure of association calculate Odds Ratio for
    prevalent disease

33
Issues in cross-sectional studies
  • Measuring prevalent disease only
  • Prevalence incorporates incidence of disease AND
    duration of disease
  • Risk factors for prevalent disease often
    different from risk factors for incident disease
  • Issues of timing (temporality) are a problem
  • Exactly when did disease develop?
  • Did exposures come before or after onset of
    disease?

34
Cohort studies
  • Start with group of individuals without the
    outcome of interest at risk
  • Follow forward in time to observe incidence of
    disease (a rate)
  • Can be descriptive or analytic
  • If analytic question, then measure exposures on
    cohort at the beginning of the study

35
Cohort studies can be purely descriptiveEg
What is the rate of remission among men treated
for prostate cancer at GSH?
Develop outcome of interest
At risk participants (without outcome)
Do not develop outcome of interest
Time
36
Analytic cohort studyEg Do ß-blockers increase
risk of renal transplant rejection?
Develop the outcome of interest
Exposure
Study population without the outcome of interest
Do not develop the outcome of interest
Develop the outcome of interest
No exposure
Do not develop outcome of interest
Time
37
Types of cohort studies
  • Prospective
  • Following cohort forward through time from
    present
  • Most common approach
  • Retrospective
  • Assemble cohort from medical records,
  • follow based on records
  • Follow-up is in the past (can extend into present)

38
Measure of association in a cohort study
relative risk (aka risk ratio, rate ratio)
New cases of outcome
Participants who do not develop outcome
A
B
Exposed
Total number of exposed A B
D
C
Unexposed
Total number of unexposed C D
Total number of participants A B C D
RR A/(AB) / C/(CD)
39
Strengths problems in cohort studies
  • Strengths
  • Can calcluate rates of new events valuable
  • Timing of exposure before disease assured
  • Good for studying health effects of rare
    exposures (can select an exposed cohort)
  • Weaknesses
  • Participants self-select their exposure status
    leads to confounding, bias
  • Take time, resources (if prospective)
  • Many subjects needed for rare outcomes

40
Randomised controlled trials
  • Principal experimental design in medical research
  • Like a cohort study, except exposure status is
    assigned by investigator (randomly) not just
    observed
  • Complex, take time ? costly
  • RCTs are usually best design for testing the
    impact of a specific intervention in improving a
    specific health outcome

41
Have outcome of interest
Exposure
Study population without the outcome of interest
Do not develop outcome of interest
Randomisation
Have outcome of interest
No exposure
Do not develop outcome of interest
Time
42
Key features of RCT
  • Randomisation
  • Removes selection bias or confounding
  • Alternation or other assignment schemes are bad
    idea
  • Use of concurrent control groups
  • Vs Before/After studies
  • Blinding whenever possible
  • Blind investigators prevents information biases
  • Blind participants prevents selective behaviour
    change during the trial
  • Not just in trials

43
  • RCTs are important tools
  • But can encounter major problems that hinder
    interpretation of results
  • Generalizability Trial participants are highly
    selected individuals
  • often not representative of general population at
    risk
  • Complexity Trials procedures can be complex (and
    costly)
  • when key design features breakdown, the
    experiment is compromised

44
Other experimental designs
  • For an experiment, need to compare 2 states with
    intervention vs without
  • Before/after studies

Introduction of Pfizer fluconazole donation
programme at GFJ
Median survival of cryptococcal meningitis in
HIV before
Median survival of cryptococcal meningitis in
HIV after
45
  • Controlled before/after studies

BEFORE
AFTER
New training in sterile procedures
MMH intervention
Rate of postoperative sepsis
Rate of postoperative sepsis
vs
No new training
NSH control
Rate of postoperative sepsis
Rate of postoperative sepsis
46
  • Time-series studies

Rate of advanced cervical cancer cases per 100,000
of pap smears performed in Western Cape
47
III. Conclusion
48
The hierarchy of study designs
  • Frequently see framework for comparing evidence
    based on the study design used
  • RCT / experiments
  • Cohort
  • Case-control
  • Cross-sectional
  • Case series/report

better evidence more valid
worse evidence less valid
49
Not (nearly) so simple
  • The study design alone does not make the evidence
    from a study better or worse
  • The details of how a study is conducted is what
    matters
  • Rigour in design, sampling, measurements,
    analysis
  • This is why the Methods section is the most
    important part of scientific papers

50
Wrap-up
  • Framework for thinking about study designs when
    developing research ideas for MMed
  • Start with a good research question
  • Understand different study design options
  • Select the most feasible study design based on
    the study question
  • Balance time, funding, available data sources
  • Understand the strengths and limitations of your
    approach
  • Be able to justify your choice of study designs

51
Resources to learn more
  • Consultations re study design, conduct, analysis
  • Ask for help before you start collecting data!!
  • Email Dr Jim teWaterNaude (to ID appropriate
    support within School of Public Health)
  • Self-learning
  • Hulley SB, Cummings SR. Designing Clinical
    Research
  • Gordis L. Epidemiology
  • Szklo M, Nieto J. Epidemiology Beyond the Basics
  • Friedman LM, Fundamentals of Clinical Trials

52
IV. Examples
53
1
  • An investigator is interested in studying the
    association between schizophrenia and measles
    vaccinations.
  • Hypothesis childhood vaccinations predispose
    individuals to develop schizophrenia in later
    life
  • What study designs are possible?
  • Which design would you recommend and why?

54
2
  • A study among outpatients attending the GSH
    diabetes clinic during 2004 collects data on 1432
    patients.
  • Each patient is included once only in the dataset
    (ie, info from their first visit during 2004)
  • Data are collected on patient family history,
    past treatment, knowledge of disease its
    management, disease severity (GTT)
  • Medicine Registrar decides to examine whether
    patients with more severe disease have better
    knowledge of disease management
  • What kind of study of this? What measures can be
    calculated?

55
3
  • You have collected records from your weekly
    clinic with information on 152 patients you have
    data on
  • patient demographic characteristics
  • detailed clinical information on morbidity
  • medical history
  • risk behaviours (smoking, drinking)
  • medications
  • You need to write an MMed. Quickly.
  • Identify a research question, a study design, and
    describe these briefly.
  • What are the strengths limitations of the study
    design you have selected in answering your
    specific question?

56
4
  • A study of neural tube defects and antenatal
    folate supplementation, lasting 10 years, follows
    10,000 pregnancies in which women used folate
    supplements, and 10,000 pregnancies in which no
    supplements were used.
  • Among women taking folate supplements, 50 cases
    of neural tube defects were observed
  • Among women not taking supplements, 150 cases of
    neural tube defects were observed.

57
4
  • What type of study is this?
  • What is the appropriate measure of association?
  • Draw up a 2x2 table, calculate the measure and
    interpret in one sentence

58
5
  • Another study of folate supplementation and
    neural tube defects uses a hospital referral
    system to identify all cases of neural tube
    defects in the local population.
  • 200 cases are identified over 10 years (50 among
    women using supplements, 150 among women not
    using supplements).
  • For comparison, investigators select 800 control
    pregnancies (where no neural tube defects were
    observed) at random from the same population (of
    whom 498 use folate supplements and 492 are
    unexposed).

59
5
  • What type of study is this?
  • What is the appropriate measure of association?
  • Draw up a 2x2 table, calculate the measure and
    interpret in one sentence.
  • Comparing 4 and 5, what is the principle
    advantage of the case-control design to cohort
    design?
Write a Comment
User Comments (0)
About PowerShow.com